Inflammation and atherosclerosis: The role of TNF and TNF receptors polymorphisms in coronary artery disease

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 1, 2007, Pages 145-154

  Sbarsi, I ^a   Falcone, C ^a   Boiocchi, C ^a   Campo, I ^b   Zorzetto, M ^b   De Silvestri, A ^a   Cuccia, Mariaclara ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Atherosclerosis; Coronary artery disease; Genetics; Inflammation; TNF; TNF receptors

Indexed keywords

TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC ANALYSIS; GENOTYPE; HEART MUSCLE ISCHEMIA; HEREDITY; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN RESISTANCE; ITALY; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR;

EID: 33947717535     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000117     Document Type: Article

References (43)

1. Cambien F., O. Poirier, C. Mallet and L. Tiret. 1997. Coronary heart disease and genetics in epidemiologist's view. Mol. Med. Today 3:197.
2. Ross R. 1999. Atherosclerosis is an inflammatory disease. Am. Heart J. 138(S):419.
3. Koenig W. 2001. Inflammation and coronary heart disease: an overview. Cardiol. Rev. 9:31.
4. Plutzky J. 2001. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am. J. Cardiol. 88:10.
5. Andreotti F., I. Porto, F. Crea and A. Maseri. 2002. Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 87:107.
6. Falcone C., I. Campo, E. Emanuele, M.P. Buzzi, M. Zorzetto, I. Sbarsi and M. Cuccia. 2004. Relationship between the -374T/A RAGE gene polymorphism and angiographic coronary artery disease. Int. J. Mol. Med. 14:1061.
7. Falcone C., I. Campo, E. Emanuele, M.P. Buzzi, D. Geroldi, C. Belvito, M. Zorzetto, I. Sbarsi and M. Cuccia. -374 T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis. Clinica Chimica Acta 354:111.
8. Barath P., M.C. Fishbein, J. Cao, J. Berenson, R.H. Helfant and J.S. Forrester. 1990. Detection and localization of tumor necrosis factor in human atheroma. Am. J. Cardiol. 65:297.
9. Tartaglia L.A. and D.V. Goeddel. 1992. Two TNF receptors. Immunol. Today 13:151.
10. Hsu H., H.B. Shu, M.G. Pan and D.V. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299.
11. Mohler K.M., D.S. Torrance, C.A. Smith, R.G. Goodwin, K.E. Stremler, V.P. Fung, H. Madani and M.B. Widmer. 1993. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immunol. 151:1548.
12. Jacob C.O., Z. Fronek, G.D. Lewis, M. Koo, J.A. Hansen and H.O. McDevitt. 1990. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 87:1233.
13. Wilson A.G., J.A. Symons, T.L. McDowell, H.O. McDevitt and G.W. Duff. 1997. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl. Acad. Sci. USA 94:3195.
14. Kroeger K.M., K.S. Carville and L.J. Abraham. 1997. The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription. Mol. Immunol. 34:391.
15. Kim J.Y., S.M. Moon, H.J. Ryu, J.J. Kim, H.T. Kim, C. Park, K. Kimm, B. Oh and J.K. Lee. 2005. Identification of regulatory polymorphisms in the TNF-TNF receptor superfamily. Immunogenetics 57:297.
16. Huizinga T.W., R.G. Westendorp, E.L. Bollen, V. Keijsers, B.M. Brinkman, J.A. Langermans, F.C. Breedveld, C.L. Verweij, L. van de Gaer, L. Dams, J.B. Crusius, A. Garcia-Gonzalez, B.W. van Oosten, C.H. Polman and A.S. Pena. 1997. TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J. Neuroimmunol. 72:149.
17. McGuire W., A.V. Hill, C.E. Allsopp, B.M. Greenwood and D. Kwiatkowski. 1994. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371:508.
18. Cabrera M., M.A. Shaw, C. Sharples, H. Williams, M. Castes, J. Convit and J.M. Blackwell. 1995. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J. Exp. Med. 182:1259.
19. Arias A.I., B. Giles, T.H. Eiermann, W. Sterry and J.P. Pandey. 1997. Tumor necrosis factor-alpha gene polymorphism in psoriasis. Exp. Clin. Immunogenet. 14:118.
20. Lio D., G. Candore, A. Colombo, G. Colonna Romano, F. Gervasi, V. Marino, L. Scola and C. Caruso. 2001. A genetically determined high setting of TNF-alpha influences immunologic parameters of HLA B8,DR3 positive subjects: implications for autoimmunity. Hum. Immunol. 62:705.
21. Cipriano C., C. Caruso, D. Lio, R. Giacconi, M. Malavolta, E. Muti, N. Gasparini, C. Franceschi and E. Mocchegiani. 2005. The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int. J. Immunogenet. 32:13.
22. Candore G., D. Lio, G. Colonna Romano and C. Caruso. 2002. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. Autoimmun. Rev. 1:29.
23. Weinshenker B.G., D. Hebrink, D.M. Wingerchuk, C.J. Klein, E. Atkinson, P.C. O'Brien and C.T. McMurray. 1999. Genetic variants in the tumor necrosis factor receptor 1 gene in patients with MS. Neurology 52:1500.
24. Ferrarotti I., M. Zorzetto, M. Beccaria, L.S. Gile, R. Porta, N. Ambrosino, P.F. Pignatti, I. Cerveri, E. Pozzi and M. Luisetti. 2003. Tumour necrosis factor family genes in a phenotype of COPD associated with emphysema. Eur. Respir. J. 21:444.
25. Komata T., N. Tsuchiya, M. Matsushita, K. Hagiwara and K. Tokunaga. 1999. Association of tumor necrosis factor receptor 2 (TNFR2) polymorphism with susceptibility to systemic lupus erythematosus. Tissue Antigens 53:527.
26. Al-Ansari A.S., W.E. Ollier, J. Villarreal, J. Ordi, L.S. The and A.H. Hajeer. 2000. Tumor necrosis factor receptor II (TNFRII) exon 6 polymorphism in systemic lupus erythematosus. Tissue Antigens 55:97.
27. Berliner J., N. Leitinger, A. Watson, J. Huber, A. Fogelman and M. Navab. 1997. Oxidized lipids in atherogenesis: formation, destruction and action. Thromb. Haemost. 78:195.
28. Bhakdi S., K.J. Lackner, S.R. Han, M. Torzewski and M. Husmann. 2004. Beyond cholesterol: the enigma of atherosclerosis revisited. Thromb. Haemost. 91:639.
29. Libby P. 2002. Inflammation in atherosclerosis. Nature 420:868.
30. Lusis A.J. 2000. Atherosclerosis. Nature 407:233.
31. Libby P. and Z.S. Galis. 1995. Cytokines regulate genes involved in atherogenesis. Ann. N. Y. Acad. Sci. 748:158.
32. Marenberg M.E., N. Risch, L.F. Berkman, B. Floderus and U. de Faire. 1994. Genetic susceptibility to death from coronary heart disease in a study of twins. N. Engl. J. Med. 330:1041.
33. Nora J.J., R.H. Lortscher, R.D. Spangler, A.H. Nora and W.J. Kimberling. 1980. Genetic - epidemiologic study of early-onset ischemic heart disease. Circulation 61:503.
34. Tabor H.K., N.J. Risch and R.M. Myers. 2002. Opinion: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat. Rev. Genet. 3:391.
35. Riccioni G., A. De Santis, V. Cerasa, V. Menna, C. Di Ilio, C. Schiavone, E. Ballone and N. D'Orazio. 2003. Atherosclerotic plaque formation and risk factors. Int. J. Immunopathol. Pharmacol. 16:25.
36. Louis E., D. Franchimont, A. Piron, Y. Gevaert, N. Schaaf-Lafontaine, S. Roland, P. Mahieu, M. Malaise, D. De Groote, R. Louis and J. Belaiche. 1998. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin. Exp. Immunol. 113:401.
37. Danis V.A., M. Millington, V. Hyland, R. Lawford, Q. Huang and D. Grennan. 1995. Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis. Markers 12:127.
38. Herrmann S.M., S. Ricard, V. Nicaud, C. Mallet, D. Arveiler, A. Evans, J.B. Ruidavets, G. Luc, L. Bara, H.J. Parra, O. Poirier and F. Cambien. 1998. Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur. J. Clin. Invest. 28:59.
39. Keso T., M. Perola, P. Lappala, E. Ilveskoski, T.A. Kunnas, J. Mikkelsson, A. Penttila, M. Hurme and P.J. Karhunen. 2001. Polymorphisms within the tumor necrosis factor locus and prevalence of coronary artery disease in middle-aged men. Atherosclerosis 154:691.
40. Pickup J.C. and M.A. Crook. 1998. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41:1241.
41. Fernandez-Real J.M., C. Gutierrez, W. Ricart, R. Casamitjana, M. Fernandez-Castaner, J. Vendrell, C. Richart and J. Soler. 1997. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 46:1468.
42. Powell E.E., C.J. Edwards-Smith, J.L. Hay, A.D. Clouston, D.H. Crawford, C Shorthouse, D.M. Purdie and J.R. Jonsson. 2000. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 31:828.
43. Perneger T.V. 1998. What's wrong with Bonferroni adjustments. BMJ 316:1236.